BRING ON THE

NEXT BIG BREAKTHROUGH

As a premier, independently owned CDMO with over 65 years of sterile injectable manufacturing experience, Simtra BioPharma Solutions (Simtra) offers world-class cGMP sterile fill/finish, technical expertise, quality service, and a uniquely collaborative approach. Pharmaceutical and biotech companies partner with Simtra when they face formulation challenges, clinical supply hurdles, surges in demand due to market fluctuations, or risk mitigation concerns. Our teams are driven to offer our clients tailored and versatile solutions to help them achieve their commercialization objectives.

For more information visit

simtrabps.com

Let’s do more, together.

Go to article: Home | Pharma casts a wide net to hook opportunities in metabolic disordersGo to article: Editor's letterGo to article: ContentsGo to article: Mimotopes Company InsightGo to article: MimotopesGo to article: DatwylerGo to article: BiomeBank Company InsightGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Project UpdatesGo to article: Molnar-Institute Company InsightGo to article: Molnar-InstituteGo to article: Allpack Group AG Company InsightGo to article: Science4TechGo to article: ZETAGo to article: In DepthGo to article: Pharma casts a wide net to hook opportunities in metabolic disorders Go to article: Alzheimer’s: drug delivery and the blood brain barrier conundrumGo to article: Era of ADCs: Pharma companies innovate to stand out in a buzzing marketGo to article: AbbVie’s Humira loss of exclusivity has been a missed opportunity for competitorsGo to article: How NVIDIA grew with the healthcare market instead of pushing into it Go to article: Sponsored SupplementsGo to article: FaravelliGo to article: Simtra BioPharma SolutionsGo to article: ListingsGo to article: EventsGo to article: Excellence AwardsGo to article: Excellence Awards 2024: TrialHubGo to article: Innovation RankingsGo to article: Buyer's GuidesGo to article: Next issue